Home/Filings/4/0001171843-25-000867
4//SEC Filing

Marshall Patrick 4

Accession 0001171843-25-000867

CIK 0001540159other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:01 PM ET

Size

11.4 KB

Accession

0001171843-25-000867

Insider Transaction Report

Form 4
Period: 2025-02-12
Transactions
  • Award

    Common Shares

    2025-02-12$1.92/sh+41,666$79,99941,666 total
Holdings
  • Common Shares

    (indirect: Held by Quidnet Inc.)
    465
Footnotes (3)
  • [F1]On February 12, 2025, the Reporting Person purchased in a private placement, 41,666 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
  • [F2]Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
  • [F3]Quidnet Inc. is wholly owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1
  • filerCIK 0001978257

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:01 PM ET
Size
11.4 KB